EditorialKommentar
Shedding Light on the Darkness of MYH7 Cardiomyopathies
JACC: Heart Failure · 2024
DOI: 10.1016/j.jchf.2023.08.009 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Paul F Kantor. Beteiligte Einrichtung: Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. …. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies, Cardiomyopathy, Hypertrophic. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Heart FailureCardiomyopathiesCardiomyopathy, HypertrophicHumansDarknessPhenotypeMutationMyosin Heavy ChainsCardiac Myosins
Stichwörter der Autor:innen
MYH7cardiomyopathypenetranceprognosisscreening
Substanzen
MYH7 protein, humanMyosin Heavy ChainsCardiac Myosins
Autor:innen und Institutionen
- Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Electronic address: pakantor@chla.usc.edu.
Zitieren
APA
Kantor, P. F. (2024). Shedding Light on the Darkness of MYH7 Cardiomyopathies. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.08.009
Vancouver
Kantor PF. Shedding Light on the Darkness of MYH7 Cardiomyopathies. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2023.08.009
BibTeX
@article{Kantor2024,
author = {Kantor, Paul F},
title = {Shedding Light on the Darkness of MYH7 Cardiomyopathies},
journal = {JACC: Heart Failure},
year = {2024},
doi = {10.1016/j.jchf.2023.08.009}
}
EUVIMED